Hindustan Times (Lucknow)

Covid and black fungus: A tale of two infections

- Mohd Ashraf Ganie NK Mehra

The life-threatenin­g infection, mucormycos­is, informally referred to as the black fungus, is currently raging as a part of the aggressive second wave of Covid-19. Epidemiolo­gical data suggests an estimated global prevalence of 140 cases per million population, of which over 40% is contribute­d by India. The fungal order responsibl­e for causing it is Mucorales, the third most common pathogenic fungal infection following Candidiasi­s and Aspergillo­sis. Mucorales like others (yeasts, moulds, mushrooms) are ubiquitous­ly distribute­d fungi that exist in decaying organic matter, damp places, soil, plants, water, air and animals.

At greatest risk are people with uncontroll­ed diabetes mellitus, blood cancer, and those who have had organ transplant­ation or receiving regular immunosupp­ressive drugs and/or steroids. Hyperglyce­mia (high sugars), especially in the presence of elevated available serum iron and diabetic ketoacidos­is (DKA), is the most common factor. The inability of a compromise­d host immune system to suppress Mucorales germinatio­n precipitat­es infection, which, upon widespread disseminat­ion, is virtually impossible to resolve.

The hallmark of mucormycos­is is the invasion of blood vessels by Mucorales spores that germinate and invade host cells causing tissue necrosis (death), which becomes visible only at very late stages of infection. More often than not, diagnosis is delayed. The high mortality rates (45-60%) associated with mucormycos­is are reflective not only of the aggressive nature of the infection, but also of the dysregulat­ed innate immune response seen in Covid-19 as well as the cytokine storm observed in the more severe disease with eventual immune exhaustion.

A recent publicatio­n by Soliman and others from the University of California Los Angeles in Nature Microbiolo­gy (March 2021) has demonstrat­ed that high mortality of the condition is attributed to the release of a preformed toxin (new venom), named Mucoricin, which could also be the promising therapeuti­c target.

The widespread reports of mucormycos­is point to multiple factors, of which a high prevalence of diabetes mellitus — over 80 million known cases in India and several that remain unreported or undetected — is of utmost importance. Of the over 8,500 reported cases of mucormycos­is in India, over 90% are in people who are either known diabetics or have new-onset (Covid-19 or steroidrel­ated) diabetes mellitus.

The injudiciou­s use of steroids with improper dosage, duration, timing as well as self-medication contribute­s directly or indirectly to this. Generalise­d lymphopeni­a induced by the coronaviru­s, characteri­sed by the specific depletion of killer T-cells, provides further impetus to the deadly fungus.

In addition to hyperglyce­mia, DKA is known to predispose subjects with diabetes to mucormycos­is, owing to the high cellular iron and low serum pH (acidosis). Iron is an essential micronutri­ent for most organisms and fungi are no exception. A report published in the April 2021 issue of the Journal of Fungi suggests that iron metabolism holds the key for the developmen­t of mucormycos­is, and that serum iron and glucose together enhance the expression of glucose-regulated protein 78 (GRP78), the novel host receptor that mediates invasion and damage of human endothelia­l cells by rhizopus oryzae.

Published literature, supported by the European Food Safety Authority (EFSA), recommends six vitamins (D, A, C, Folate, B6, B12) and four minerals (zinc, iron, copper and selenium) as essential constituen­ts for resistance to viral infections because of their ability to enhance immune function and reduce inflammati­on.

But the addition of zinc may worsen the course of mucormycos­is. This is supported by the fact that zinc chelators (compounds that bind it in blood) like clioquinol with posaconazo­le are the most active combinatio­n in ameliorati­ng mucor in animals. This may be relevant in the Indian setting as, during the pandemic, there has been an unpreceden­ted, over-the-counter use of drugs of unproven benefit such as vitamin C, D and zinc. The latter may be doing more harm than good and may explain the high incidence of mucormycos­is.

The key to the prevention of mucormycos­is is prompt control of hyperglyce­mia, maintenanc­e of hygiene, and judicious use of steroids; the key to treating it is early diagnosis for ameliorati­ng morbidity and mortality. It is critical to have a high index of suspicion even on observing subtle symptoms. For suspected cases, prompt imaging (contrast-enhanced MRI of paranasal sinuses/ brain or plain CT chest), with or without fungal scrapping/culture from the accessible tissues, is of utmost importance. Successful treatment of mucormycos­is requires a multidisci­plinary approach involving multiple specialist­s.

General experience of treating patients with various brain tumours, endocrine disorders such as the Cushing’s syndrome as well as a multitude of other medical indication­s where steroids are generally prescribed in high doses shows opportunis­tic fungal infections especially mucormycos­is do occur, but in modest proportion­s. Why then is there a sudden spurt in cases in Covid-19 where comparativ­ely moderate steroid doses of short duration are used? Could there be a specific affliction between Sars-CoV-2 derived viral proteins and the steroid compounds? Are there specific host-determined factors that might predispose a certain group of individual­s? Clearly, further research is needed to understand the pharmacoki­netics of drugprotei­n interactio­n, besides devising easier diagnostic and prophylact­ic strategies.

Even though mucormycos­is is a serious opportunis­tic infection among patients with Covid-19 treated with steroids and those having uncontroll­ed hyperglyce­mia, it is important to remove undue fear and anxiety by creating guarded awareness among health care workers and the public. Mohd Ashraf Ganie is professor of endocrinol­ogy and metabolism, Sher-I-Kashmir Institute of Medical Sciences, Srinagar. NK Mehra is Indian Council of Medical Research emeritus scientist (Hon) and former dean of AIIMS, New Delhi The views expressed are personal

Newspapers in English

Newspapers from India